Correction to: Differentiating societal costs of disability worsening in multiple sclerosis

Affiliations

¹ MS Center, Center of Clinical Neuroscience, Department of Neurology, University Hospital Carl Gustav Carus, Fetscherstr. 74, 01307, Dresden, Germany.
² Novartis Pharma GmbH, Nuremberg, Germany.
³ Siemens Healthineers AG, Erlangen, Germany.
⁴ MS Center, Center of Clinical Neuroscience, Department of Neurology, University Hospital Carl Gustav Carus, Fetscherstr. 74, 01307, Dresden, Germany. Tjalf.Ziemssen@uniklinikum-dresden.de.

Published Erratum

Nils-Henning Ness et al. J Neurol. 2020 Apr.

. 2020 Apr;267(4):1043-1044.

doi: 10.1007/s00415-019-09694-2.

¹ MS Center, Center of Clinical Neuroscience, Department of Neurology, University Hospital Carl Gustav Carus, Fetscherstr. 74, 01307, Dresden, Germany.
² Novartis Pharma GmbH, Nuremberg, Germany.
³ Siemens Healthineers AG, Erlangen, Germany.
⁴ MS Center, Center of Clinical Neuroscience, Department of Neurology, University Hospital Carl Gustav Carus, Fetscherstr. 74, 01307, Dresden, Germany. Tjalf.Ziemssen@uniklinikum-dresden.de.

Abstract

The original version of this article unfortunately contained a mistake. The captions of Fig. 2 and Fig. 3 are mismatched.

Differentiating societal costs of disability worsening in multiple sclerosis.
Ness NH, Schriefer D, Haase R, Ettle B, Cornelissen C, Ziemssen T. Ness NH, et al. J Neurol. 2020 Apr;267(4):1035-1042. doi: 10.1007/s00415-019-09676-4. Epub 2019 Dec 17. J Neurol. 2020. PMID: 31848738